Elevance $342M MA Overbilling Settlement
A single wire transfer just revealed that Medicare Advantage has been draining taxpayer money through inflated billing codes for decades, and the federal government is finally collecting.
On May 27, 2026, Elevance Health sent a wire transfer to the federal government for $342 million.
No press conference. No announcement. Government lawyers disclosed it quietly in a June 22 court filing.
But the implications of that payment are anything but quiet. This is the most significant Medicare Advantage enforcement action in years. And it is a signal that the compliance era for the MA industry has arrived with real teeth.
Elevance settlement figures at a glance
1. What Actually Happened at Elevance
The story starts in February 2026.
CMS sent Elevance Health a formal notice threatening to suspend new enrollment across the insurer's Medicare Advantage prescription drug contracts. The agency alleged what it called "substantial and persistent noncompliance" with federal rules governing risk adjustment data submission.
Enrollment suspension is not a slap on the wrist. Elevance covers approximately 2 million Medicare Advantage members. Blocking new enrollments mid-year is an existential operational threat. It signals to the market, to members, and to investors that the plan's credibility with CMS is in question.
And here is the part that matters most: the underlying compliance failure was not subtle.
Over the previous seven years, Elevance had been submitting risk adjustment data via flash drives instead of through CMS's required electronic systems. The agency had repeatedly warned against this method. Elevance kept doing it anyway.
CMS had been flagging this methodology problem for seven years before taking formal action.
In response to the February notice, Elevance disclosed that it had set aside $935 million as its best estimate of total financial exposure from the issue. That $935 million figure came from CFO Mark Kaye during the company's first-quarter earnings call on April 22, 2026.
Then on May 27, Elevance sent $342 million as a partial settlement.
Additional tasks remain. CMS has set deadlines through the end of June and into July for Elevance to resolve issues across other risk-adjustment modules and address remaining overpayment concerns. The sanctions clock has not fully stopped.
Elevance is not done with this story. And neither is the industry.
Healthcare compliance audit in progress
2. Medicare Advantage's Overbilling Problem: How the System Works
To understand why this matters, you need to understand how Medicare Advantage actually gets paid.
In traditional Medicare, the government pays providers directly based on services rendered. In Medicare Advantage, the government pays insurers a monthly capitation rate per enrolled member. That rate is adjusted upward based on how sick the member is. Sicker members generate higher payments.
The tool used to measure sickness is called risk adjustment. It works through diagnosis codes. When a physician documents a diagnosis for a patient, that code gets submitted to the insurer, who submits it to CMS, which uses it to calibrate the capitation payment.
A diabetic patient generates more payment than a healthy one. A diabetic patient with complications generates even more. A patient with multiple chronic conditions generates more still.
Here is where the problem enters.
Insurers have a direct financial incentive to submit as many high-severity diagnosis codes as possible. More codes, especially for more serious conditions, mean higher capitation payments. Conversely, codes that are not supported by actual clinical documentation should not be submitted. But the line between aggressive, good-faith coding and fraudulent upcoding is exactly where enforcement is focused.
CMS estimates 9.5% of all Medicare Advantage payments are improper, driven primarily by unsupported diagnosis codes submitted by MA organizations.
The scale of the problem is staggering.
MedPAC, the independent advisory body that monitors Medicare programs, concluded in its March 2024 report that MA plans were overpaid by approximately $83 billion in 2024 alone. That figure represents 22 percent more than what Medicare would have paid for the same patients in traditional fee-for-service Medicare.
The Committee for a Responsible Federal Budget projects that coding intensity and favorable patient selection will result in MA plans being overpaid by $1.2 trillion over the 2025 to 2034 decade. Half of that, $520 billion, will come directly from the Medicare Hospital Insurance trust fund.
This is not a rounding error. It is a structural flaw in the payment model that has been documented for years and largely tolerated because of the political complexity of reform.
Until now.
3. The Enforcement Era: A Settlement Scoreboard
The Elevance payment is not happening in isolation. It is part of an accelerating pattern.
Major MA risk adjustment enforcement actions 2023-2026
In January 2026, Kaiser Permanente affiliates agreed to pay $556 million to resolve False Claims Act allegations. That settlement is the largest MA risk adjustment fraud settlement in history. The government alleged Kaiser physicians were pressured to add diagnoses after patient visits through post-hoc medical record addenda, generating approximately $1 billion in additional Medicare payments over a nine-year period.
In 2025 alone, the Department of Justice secured $5.7 billion in False Claims Act settlements and judgments from healthcare cases. The DOJ has publicly stated that Medicare Advantage enforcement is now its number one priority in healthcare.
The OIG issued its first Medicare Advantage-specific compliance program guidance since 1999 on February 2, 2026. That guidance matters because it signals that the regulators view MA compliance as a distinct discipline requiring its own standards, not just a subset of general healthcare compliance.
And CMS is scaling its enforcement infrastructure dramatically. The agency is expanding its team of medical coders from 40 to approximately 2,000 individuals, with the target of auditing every one of the 550 MA contracts annually.
CMS is scaling from 40 to 2,000 medical coders, with a target of auditing all 550 MA contracts per year.
The math on that scaling is significant. At 40 coders, CMS could audit a small fraction of plan submissions. At 2,000, the agency can sustain the kind of systematic review that makes fraudulent submission strategies genuinely risky.
Federal officials reviewing Medicare Advantage compliance files
4. What the Denial Data Reveals About the Other Side
While regulators are focused on MA plans submitting false diagnoses to collect inflated payments, a parallel crisis is documented in what happens to patients when they actually try to use their coverage.
The Medicare Rights Center published data in June 2026 showing the denial rates for post-acute care among the three largest Medicare Advantage organizations.
MA post-acute care denial rates by insurer (June 2026)
Long-term care hospitals and inpatient rehabilitation facilities serve patients with the most medically complex needs. Stroke survivors. Patients recovering from cardiac events. People who have just had amputations or traumatic brain injuries. These are not elective services.
CVS denied 80 percent of initial requests to enter a long-term care hospital. Humana denied 72 percent. UnitedHealth denied 71 percent.
When patients appealed, 36 percent of long-term care hospital denials were reversed. Forty-three percent of inpatient rehabilitation denials were reversed on appeal.
That reversal rate is critical. It tells you that a substantial portion of the denied claims were medically appropriate. Denials are not being generated by careful clinical review finding genuine ineligibility. They are being generated by a default-to-deny system that counts on patients not knowing how to appeal, being too sick to navigate the process, or simply giving up.
Together, UnitedHealth, Humana, and CVS cover nearly 20 million Medicare Advantage members. The denial policies of these three plans are not statistical outliers. They are the system.
MA post-acute care denial rates by insurer (June 2026)
The two-sided nature of the MA accountability crisis is now visible.
On the revenue side: plans submit inflated diagnoses to collect higher payments from CMS.
On the care side: plans deny medically necessary services to reduce the cost of delivering that care.
The business model optimizes both levers simultaneously. Maximize revenue from the government. Minimize payouts to patients and providers. The $342 million settlement is what happens when the first lever finally gets enforced.
5. Deep Dive: The $1.2 Trillion Problem and What Fixes It
The Elevance settlement is a meaningful data point. But at $342 million against a projected $1.2 trillion in MA overpayments over the next decade, it is also clear that individual enforcement actions are not going to close the gap.
Annual MA overpayment sources: 2024 estimate (MedPAC)
The structural issue is the risk adjustment model itself.
CMS has been phasing in a revised risk adjustment model called V28 since 2024. V28 is designed to reduce coding intensity adjustments and more accurately calibrate payments based on actual patient complexity. MA plans vigorously opposed V28, arguing it would destabilize their financial models.
They were partially right, which is why MA enrollment growth decelerated significantly in 2025 and 2026. Several major plans exited markets or scaled back benefits. UnitedHealth lost nearly 647,000 MA members between March 2025 and March 2026. Elevance lost 346,000. The market is repricing against tighter enforcement and tighter payment models simultaneously.
Scenario A: Aggressive Enforcement Only
If enforcement continues at the current trajectory without structural payment reform, the government will collect additional settlements, probably reaching a few billion dollars per year. But the risk adjustment coding incentive remains. Plans will adapt their compliance programs while continuing to optimize code submissions. The overpayment problem moderates but does not resolve.
Scenario B: V28 + Enforcement Combined
The combination of V28 payment reform and active enforcement creates meaningful structural change. CMS's 2,000-coder audit capacity makes systematic coding schemes genuinely risky. V28 reduces the financial reward from coding intensity. This is the current trajectory. Estimates suggest this could reduce overpayments from the projected $1.2 trillion to something closer to $800 billion over the decade, a real improvement but still significant.
Scenario C: Fundamental Risk Adjustment Reform
A redesigned risk adjustment model that relies on prospective clinical data rather than retrospective diagnosis code submissions would remove the post-visit addenda opportunity that produced the Kaiser settlement. Several policy researchers have proposed encounter-based or episode-based payment models. These are politically complex and face intense industry opposition, but they represent the only path to genuinely closing the gap.
V28 payment reforms are projected to reduce MA overpayments by approximately 34 percent compared to the prior model, but the absolute dollar amount remains in the hundreds of billions.
6. What This Means for Providers
The Elevance settlement matters to providers not because of the dollar figure, but because of what it signals about the operating environment.
If CMS is enforcing MA risk adjustment compliance with enrollment suspension threats, plans will respond. They always do. The question is how.
One response is genuine compliance improvement. Plans invest in documentation standards, audit their code submission processes, and stop submitting unsupported diagnoses. This is the best outcome for the system and for patients.
The second response is more aggressive denial behavior on the claims side to offset revenue pressure. If plans can no longer generate the same margins from coding, they may attempt to recover margin by reducing payouts. The denial rate data already shows this pattern at scale.
For FQHCs and safety-net providers, the implications are direct. MA membership is a growing share of patient panels at community health centers. Between 2020 and 2025, MA enrollment grew from 24.1 million to approximately 35 million, now representing 55 percent of all Medicare beneficiaries. Many of those new MA enrollees came from lower-income and higher-complexity populations.
When your MA members face post-acute denials, the FQHC absorbs the referral disruption, the care coordination burden, and often the cost of the patient returning sicker after a premature discharge.
Elevance settlement: who wins and who loses
What This Means For You
For FQHC executives and community health leaders:
Your MA patient panels are growing. Know your payer-specific denial rates for post-acute referrals. Document the clinical basis for every referral at the time of the encounter, not after a denial arrives.
MA compliance pressure on plans does not reduce your administrative burden. It may increase it as plans tighten prior authorization documentation requirements.
Build appeal capacity now. The reversal rates on MA post-acute denials (36-43 percent on appeal) mean that fighting denials generates real revenue recovery.
Engage your state Medicaid agency and advocacy organizations on the overlap between MA enforcement and FQHC reimbursement policy. These conversations are connected.
For health system administrators and CMOs:
Risk adjustment audit exposure is now shared risk for health systems that operate MA-adjacent billing workflows. Review your documentation standards for diagnosis code submissions.
The V28 payment model change and enforcement expansion are compressing MA margins simultaneously. Plans that cannot absorb that margin pressure will exit markets or reduce benefits. Model your MA census exposure now.
Post-acute denial rates at 65-80 percent industry-wide mean that every inpatient discharge to a skilled nursing facility or rehab involves a probable MA authorization fight. Build that into your case management workflow and staffing model.
For healthcare investors and founders:
MA compliance technology is a growing market. Audit support, documentation quality, and risk adjustment accuracy tools all have tailwind from the enforcement era.
The plans that survive the enforcement and payment reform transition will be the ones with genuine compliance infrastructure, not just legal reserves.
The denial-side problem creates opportunity for patient advocacy and appeals automation tools, particularly for post-acute care workflows.
For radiologists and pulmonologists:
If your imaging practice has MA contracts, review how your diagnosis documentation is submitted through your billing chain. The coding path between your report and the MA plan's risk adjustment submission is often longer and more opaque than you realize.
Lung cancer diagnosis coding has specific risk adjustment value in MA plans. Ensure your clinical documentation supports the specificity of any diagnosis codes being submitted on your behalf.
The Boldest Truth
Medicare Advantage was marketed as a better version of Medicare. Private-sector efficiency, extra benefits, lower out-of-pocket costs.
What we built instead is a system where private insurers collect a government check sized by how sick their members appear to be, then deny care to those same sick members at rates that would be scandalous if they were printed in a newspaper without context.
An 80 percent denial rate for long-term care hospitals is not utilization management. It is revenue protection dressed in clinical language. And a $342 million settlement for submitting seven years of flash-drive data instead of using the electronic systems CMS required is not just a compliance failure. It is a systemic prioritization of revenue optimization over accountability.
The $342 million Elevance paid to CMS is the beginning of a reckoning, not the end of it. The DOJ has active investigations across the industry. CMS is scaling its audit capacity by 50 times. The OIG issued new compliance guidance for the first time in 27 years.
The enrollment suspension threat worked once. It will be used again.
For every Medicare Advantage plan operating in this environment, the question is not whether this will affect you. It is whether you are positioning your compliance infrastructure to survive it, or hoping the auditors run out of time before they get to your contracts.
They are hiring 2,000 coders. They will not run out of time.
About the Author
Jonathan Govette is the Co-Founder and CEO of Oatmeal Health, an AI lung cancer diagnostic company catching cancers earlier in the communities that need it most. Oatmeal uses AI to identify unscreened high-risk patients, navigate them to care, and score every lung CT for malignancy risk - billed under CPT 0721T. Stage I survival is 77%. Stage IV is 9%. We work in FQHCs because that gap is largest there.
Jonathan writes daily about radiology, pulmonology, AI diagnostics, health policy, hospital operations, and healthcare startups.
Subscribe to stay ahead of healthcare's most important shifts. Weekly deep-dives on AI, radiology, health policy, FQHCs, and the business of healthcare - written for operators, clinicians, and investors who want the signal, not the noise.
Key References
KFF Health News: Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe (June 2026) - https://kffhealthnews.org/medicare/medicare-advantage-cms-elevance-crackdown-overcharging-payment/
DOJ Office of Public Affairs: Kaiser Permanente Affiliates Pay $556M to Resolve False Claims Act Allegations (January 2026)
MedPAC: March 2024 Report to Congress - MA overpayments estimated at $83 billion in 2024 (22% above traditional Medicare)
Medicare Rights Center: Largest MA Organizations Have Disproportionate Denial Rates for Some Post-Acute Care (June 2026)
Becker's Payer Issues: Elevance sets aside $935M over Medicare Advantage enrollment threat